Clinical Trial Update: Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study [Phase 2]

View source ↗

Summary

Prospective Phase II randomized multicenter trial evaluating prolonged anticoagulation for primary prevention of venous thromboembolism in autoimmune hemolytic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Venous Thromboembolism

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Prolonged Anticoagulation, Venous Thromboembolic Disease | Phase 2 | Status: RECRUITING